School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China.
J Ethnopharmacol. 2010 Aug 19;131(1):95-103. doi: 10.1016/j.jep.2010.06.007. Epub 2010 Jun 15.
Scutellaria barbata is a traditional Chinese medicine for cancer treatments. Pheophorbide-a (Pa), one of the active components isolated from this herbal medicine has been proposed to be a potential natural photosensitizer for photodynamic therapy. The anti-tumor effect of pheophorbide-a based photodynamic therapy (Pa-PDT) has been successfully demonstrated in a wide range of human malignant cell lines. However, the effectiveness of Pa-PDT has not yet been evaluated on human breast cancer, which is documented as the second common and the fifth most lethal cancer worldwide.
The cytotoxicity of Pa-PDT was evaluated by using an estrogen receptor (ER)-negative human breast adenocarcinoma cell line MDA-MB-231. The involvement of mitochondria was revealed by the change of mitochondrial membrane potential and the increase of intracellular reactive oxygen species (ROS). The hallmarks of apoptosis, ER stress and autophagy were also assessed by DNA fragmentation, Western blotting, and immunostaining assays.
Pa-PDT showed inhibitory effect on the growth of MDA-MB-231 cells with an IC(50) value of 0.5 microM at 24h. Mitogen-activated protein kinase (MAPK) pathway was found to be triggered, where activation of c-Jun N-terminal kinase (JNK) and inhibition of extracellular signal-regulated kinase (ERK) were occurred in the Pa-PDT-treated cells. Our findings suggested that Pa-PDT exhibited its anti-tumor effects by the activation of mitochondria-mediated apoptosis and the ERK-mediated autophagy in MDA-MB-231 cells.
The present study suggested Pa-PDT is a potential protocol for the late phase human breast cancer, and it is the first study to demonstrate the Pa-PDT induced autophagy contributed to the anti-tumor effects of Pa-PDT on human cancer cells.
黄芩是一种传统的中药,用于癌症治疗。从这种草药中分离出的活性成分之一的原卟啉 a(Pa)已被提议作为光动力疗法的潜在天然光敏剂。基于原卟啉 a 的光动力疗法(Pa-PDT)已在广泛的人类恶性细胞系中成功证明了其抗肿瘤作用。然而,Pa-PDT 的有效性尚未在人类乳腺癌中进行评估,乳腺癌是全球第二常见和第五大最致命的癌症。
通过使用雌激素受体(ER)阴性人乳腺癌腺癌细胞系 MDA-MB-231 评估 Pa-PDT 的细胞毒性。通过线粒体膜电位的变化和细胞内活性氧(ROS)的增加来揭示线粒体的参与。还通过 DNA 片段化、Western 印迹和免疫染色测定评估凋亡、内质网应激和自噬的特征。
Pa-PDT 对 MDA-MB-231 细胞的生长具有抑制作用,在 24 小时时 IC(50)值为 0.5 microM。发现有丝分裂原激活的蛋白激酶(MAPK)途径被触发,其中 Pa-PDT 处理的细胞中 c-Jun N-末端激酶(JNK)的激活和细胞外信号调节激酶(ERK)的抑制。我们的研究结果表明,Pa-PDT 通过激活线粒体介导的细胞凋亡和 ERK 介导的自噬来发挥其抗肿瘤作用。
本研究表明 Pa-PDT 是晚期人类乳腺癌的一种潜在方案,并且是首次证明 Pa-PDT 诱导的自噬有助于 Pa-PDT 对人类癌细胞的抗肿瘤作用。